Skip to main content
Surmodics, Inc. (SRDX)
Nov 19, 2025 - SRDX was delisted (reason: acquired by GTCR affiliate)
42.98
+0.15 (0.35%)
Inactive · Last trade price on Nov 18, 2025

Revenue by Product

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
Medical Device
97.51M
Log In
Log In
Log In
Log In
Upgrade
Medical Device Growth
-7.82%
Log In
Log In
Log In
Log In
Upgrade
In Vitro Diagnostics
28.57M
Log In
Log In
Log In
Log In
Upgrade
In Vitro Diagnostics Growth
6.60%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
United States
104.64M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-3.75%
Log In
Log In
Log In
Log In
Upgrade
Foreign
21.43M
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
-10.19%
Log In
Log In
Log In
Log In
Upgrade